Aduhelm Side Effects, Uses, Interactions, Pictures, Warnings & Dosing

- ADUHELM
- QTY 1.7
- 170 MG/1.7
- VIAL
- - Near 77381

ADUCANUMAB (A due KAN ue mab) is used to treat patients with mild or early stages of Alzheimer's disease.

ADUHELM Information

What is this medication?
How should I use this medication?

This medication is injected into a vein. It is given by your care team in a hospital or clinic setting.
A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time.
Talk to your care team about the use of this medicine in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.
What may interact with this medication?
What should I watch for while using this medication?
What if I miss a dose?
What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:
-Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
-Swelling or small amounts of bleeding in the brain—headache, confusion, dizziness, falls, nausea, seizures, vision changes
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
-Diarrhea

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Where should I keep my medication?

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.